AT256355B - Verfahren zur Herstellung von neuen ungesättigten 17-Alkylsteroidketonen - Google Patents

Verfahren zur Herstellung von neuen ungesättigten 17-Alkylsteroidketonen

Info

Publication number
AT256355B
AT256355B AT825762A AT825762A AT256355B AT 256355 B AT256355 B AT 256355B AT 825762 A AT825762 A AT 825762A AT 825762 A AT825762 A AT 825762A AT 256355 B AT256355 B AT 256355B
Authority
AT
Austria
Prior art keywords
preparation
new unsaturated
steroid ketones
alkyl steroid
alkyl
Prior art date
Application number
AT825762A
Other languages
English (en)
Inventor
Alan Dr Hughes Gordon
Herchel Dr Smith
Original Assignee
Smith Herchel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Herchel filed Critical Smith Herchel
Application granted granted Critical
Publication of AT256355B publication Critical patent/AT256355B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A43FOOTWEAR
    • A43BCHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B3/00Footwear characterised by the shape or the use
    • A43B3/12Sandals; Strap guides thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Woven Fabrics (AREA)
AT825762A 1961-10-19 1962-10-19 Verfahren zur Herstellung von neuen ungesättigten 17-Alkylsteroidketonen AT256355B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB37618/61A GB1041279A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketones

Publications (1)

Publication Number Publication Date
AT256355B true AT256355B (de) 1967-08-25

Family

ID=10397775

Family Applications (4)

Application Number Title Priority Date Filing Date
AT822762A AT264730B (de) 1961-10-19 1962-10-18 Verfahren zur Herstellung von neuen Steroidketonen
AT825762A AT256355B (de) 1961-10-19 1962-10-19 Verfahren zur Herstellung von neuen ungesättigten 17-Alkylsteroidketonen
AT825662A AT256354B (de) 1961-10-19 1962-10-19 Verfahren zur Herstellung von neuen ungesättigten Steroidketonen
AT825862A AT256356B (de) 1961-10-19 1962-10-19 Verfahren zur Herstellung von neuen 17-Alkyl-steroidketonen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT822762A AT264730B (de) 1961-10-19 1962-10-18 Verfahren zur Herstellung von neuen Steroidketonen

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT825662A AT256354B (de) 1961-10-19 1962-10-19 Verfahren zur Herstellung von neuen ungesättigten Steroidketonen
AT825862A AT256356B (de) 1961-10-19 1962-10-19 Verfahren zur Herstellung von neuen 17-Alkyl-steroidketonen

Country Status (12)

Country Link
AT (4) AT264730B (de)
CH (5) CH455763A (de)
CY (1) CY429A (de)
DE (4) DE1468604C2 (de)
DK (6) DK113641B (de)
ES (1) ES281669A1 (de)
FI (4) FI41027B (de)
FR (1) FR2796M (de)
GB (2) GB1041279A (de)
MY (1) MY6800075A (de)
NO (4) NO122646B (de)
SE (6) SE312552B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2636404C2 (de) * 1976-08-12 1983-12-08 Schering AG, 1000 Berlin und 4709 Bergkamen Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN104926906B (zh) * 2015-06-04 2016-02-10 保定北瑞甾体生物有限公司 一种17α-羟基黄体酮的制备方法

Also Published As

Publication number Publication date
NO122644B (de) 1971-07-26
NO122646B (de) 1971-07-26
DE1468604C2 (de) 1971-03-04
FI41026B (de) 1969-04-30
SE335526B (de) 1971-06-01
DE1618855C3 (de) 1973-10-25
SE312553B (de) 1969-07-21
DE1793608B1 (de) 1972-05-04
NO122645B (de) 1971-07-26
DK115549B (da) 1969-10-20
AT264730B (de) 1968-09-10
CH459195A (de) 1968-07-15
AT256356B (de) 1967-08-25
SE340619B (de) 1971-11-29
DK129652B (da) 1974-11-04
SE312552B (de) 1969-07-21
DE1617818B2 (de) 1976-12-09
SE313809B (de) 1969-08-25
GB1041279A (en) 1966-09-01
DK124753B (da) 1972-11-20
DE1793595B2 (de) 1975-10-30
DE1618855B2 (de) 1973-04-05
DE1618855A1 (de) 1972-05-18
AT256354B (de) 1967-08-25
MY6800075A (en) 1968-12-31
FI41024B (de) 1969-04-30
CH455763A (de) 1968-05-15
SE312551B (de) 1969-07-21
CH432509A (de) 1967-03-31
CH450407A (de) 1968-01-31
GB1041278A (en) 1966-09-01
DE1468604B1 (de) 1970-07-02
ES281669A1 (es) 1963-03-16
DE1617818A1 (de) 1972-05-18
FR2796M (fr) 1964-09-21
FI41027B (de) 1969-04-30
CY429A (en) 1968-01-15
CH450408A (de) 1968-01-31
DK113641B (da) 1969-04-14
FI41025B (de) 1969-04-30
DE1793595A1 (de) 1972-02-03
DK115621B (da) 1969-10-27
DK121228B (da) 1971-09-27
NO122643B (de) 1971-07-26
DK129652C (de) 1975-04-07

Similar Documents

Publication Publication Date Title
CH429716A (de) Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden
AT244317B (de) Verfahren zur Herstellung von neuen Farnesylesigsäureestern
AT239788B (de) Verfahren zur Herstellung von neuen β-Carbolin-carbonsäureamid-Derivaten
CH437336A (de) Verfahren zur Herstellung von neuen Dihalogen-amino-benzylaminen
AT256355B (de) Verfahren zur Herstellung von neuen ungesättigten 17-Alkylsteroidketonen
CH433274A (de) Verfahren zur Herstellung von Steroid-Guanylhydrazonen
AT269376B (de) Verfahren zur Herstellung von neuen Steroidketonen
CH448074A (de) Verfahren zur Herstellung von neuen 19-Hydroxysteroiden
AT230894B (de) Verfahren zur Herstellung von neuen Pyridazinderivaten
CH413835A (de) Verfahren zur Herstellung von 21-phosphorylierten Steroiden der Pregnanreihe
CH401044A (de) Verfahren zur Herstellung von neuen 16a-Fluormethylsteroiden
CH429693A (de) Verfahren zur Herstellung von neuen Azidobenzolsulfonylharnstoffen
CH402854A (de) Verfahren zur Herstellung von 6a-Difluormethylsteroiden
CH434246A (de) Verfahren zur Herstellung von fluorierten steroiden Pyrazolverbindungen
AT249890B (de) Verfahren zur Herstellung von neuen ungesättigten 16-Methylen-3-keto-steroiden
CH396893A (de) Verfahren zur Herstellung von neuen 10-Alkenylsteroiden
CH437273A (de) Verfahren zur Herstellung von neuen Steroiden
CH441339A (de) Verfahren zur Herstellung von neuen Oxopyrimidinen
CH422770A (de) Verfahren zur Herstellung von 15-Methylsteroiden
CH424772A (de) Verfahren zur Herstellung von 12-Aminosteroiden
AT241472B (de) Verfahren zur Herstellung von neuen 1-Azathiaxanthenderivaten
CH420137A (de) Verfahren zur Herstellung von ungesättigten 6-Methyl-16-methylen-3-keto-steroiden
CH425781A (de) Verfahren zur Herstellung von ungesättigten 16-Methylen-3-keto-steroiden
AT248626B (de) Verfahren zur Herstellung von neuen 19-Hydroxysteroiden
AT239796B (de) Verfahren zur Herstellung von neuen Benzolsulfonyl-alkylen-semicarbaziden